Menu
Recruiting NCT07673380

Leveraging mHealth to Promote Opioid Use Recovery and Mental Health Among Residents of a Medium-Sized Midwestern City

Phase II Interventional Opioid Use Stimulant Use Depression and Anxiety Symptoms

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: uMAT-R + enhanced community engagement, Original uMAT-R supplementary mHealth recovery intervention.
Who it may be relevant to
Registry conditions: Opioid Use, Stimulant Use, Depression and Anxiety Symptoms. Basic parameters: from 18 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
United States
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

Leveraging mHealth to Promote Recovery From Opioid Use Disorder and Commonly Occurring Mental Health Disorders Among Residents of a Medium-Sized Midwestern City

Overview

The sequential trial compares recovery and mHealth engagement outcomes among Black participants who participated in the mHealth intervention uMAT-R or uMAT-R + enhanced community engagement. The mHealth intervention seeks to support people in various stages of recovery who are also seeking other forms of substance use treatment. Participants are recruited from community-based substance use treatment facilities and recovery services. Participants must be adults who have or are currently using opioids and/or stimulants.

Interventions

  • Behavioral uMAT-R + enhanced community engagement
    uMAT-R + enhanced community engagement involves an optimized community engagement strategy employed by the intervention team. This involves in-person interactions with eligible participants and recruitment sites.
  • Behavioral Original uMAT-R supplementary mHealth recovery intervention
    uMAT-R supplementary mHealth recovery intervention is the original intervention without optimization of the community engagement approach.

Primary outcome measures

  • Abstinence/ Changes in Substance Use [Time frame: Time 0 (Baseline) and Time 1 (One Month)]
  • Opioid use/ Stimulant use disorder symptoms [Time frame: Time 0 (Baseline) and Time 1 (One Month)]
Secondary outcome measures (5)
  • Depression symptoms [Time frame: Time 0 (Baseline) and Time 1 (One-Month)]
  • Anxiety Symptoms [Time frame: Time 0 (Baseline) and Time 1 (One-Month)]
  • Basic needs [Time frame: Time 0 (Baseline) and Time 1 (One-Month)]
  • Medication for Opioid Use Disorder (MOUD) Attitudes [Time frame: Time 0 (Baseline), and Time 1 (One-Month)]
  • Substance Use Disorder (SUD) Treatment Engagement [Time frame: Time 0 (Baseline), and Time 1 (One-Month)]

Eligibility criteria

Inclusion criteria

  • Have a history of opioid and/or stimulant use
  • Identify as Black and/or African American
  • Seek treatment at local substance use treatment centers
  • Fluent in English
  • U.S. resident
  • 18 years of age or older at the time of data collection.

Exclusion criteria

  • Self-reported cognitive impairment that would limit ability to participate in research.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
Non-randomized
Model
Sequential
Masking
Open label
Primary purpose
Supportive care

Study locations

United States · 1 center
  • Washington University School of Medicine — St Louis

Identifiers

NCT: NCT07673380 · 202308065

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗